PATENT CLAIM ANALYSIS

Application Number: 15915637
Application Type: Utility
Filing Date: 2018-03
Publication Date: 2018-07
Patent Classification: ["424", "093710"]

Abstract:
Provided are methods for improving cell-based therapies by co-administration with an agent that increases the production and or levels of epoxygenated fatty acids, as well as kits, stents and patches for co-administering stem cells with an agent that increases the production and/or levels of epoxygenated fatty acids.

Claim (Index 59):
The kit, stent or patch of any one of  claims 52  to  58 , wherein the inhibitor of sEH is selected from the group consisting of:\n a) 3-(4-chlorophenyl)-1-(3,4-dichlorphenyl)urea or 3,4,4\u2032-trichlorocarbanilide (TCC; compound 295); \n b) 12-(3-adamantan-1-yl-ureido) dodecanoic acid (AUDA; compound 700); \n c) 1-adamantanyl-3-{5-[2-(2-ethoxyethoxy)ethoxy]pentyl]}urea (AEPU; compound 950); \n d) 1-(1-acetypiperidin-4-yl)-3-adamantanylurea (APAU; compound 1153); \n e) trans-4-[4-(3-Adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (tAUCB; compound 1471); \n f) cis-4-[4-(3-Adamantan-1-yl-ureido)-cyclohexyloxy]-benzoic acid (cAUCB; compound 1686); \n g) 1-(1-methylsulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea (TUPS; compound 1709); \n h) trans-4-{4-[3-(4-Trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy}-benzoic acid (tTUCB; compound 1728); \n i) 1-trifluoromethoxyphenyl-3-(1-propionylpiperidin-4-yl) urea (TPPU; compound 1770); \n j) 1-(1-ethyl sulfonyl-piperidin-4-yl)-3-(4-trifluoromethoxy-phenyl)-urea (TUPSE; compound 2213); \n k) 1-(1-(cyclopropanecarbonyl)piperidin-4-yl)-3-(4-(trifluoromethoxy)phenyl)urea (CPTU; compound 2214); \n l) trans-N-methyl-4-[4-(3-Adamantan-1-yl-ureido)-cyclohexyloxy]-benzamide (tMAUCB; compound 2225); \n m) trans-N-methyl-4-[4-((3-trifluoromethyl-4-chlorophenyl)-ureido)-cyclohexyloxy]-benzamide (tMTCUCB; compound 2226); \n n) cis-N-methyl-4-{4-[3-(4-trifluoromethoxy-phenyl)-ureido]-cyclohexyloxy}-benzamide (cMTUCB; compound 2228); and \n o) 1-cycloheptyl-3-(3-(1,5-diphenyl-1H-pyrazol-3-yl)propyl)urea (HDP 3 U; compound 2247).

Metadata:
- Claim Count in Document: 5.0
- Percentile: 90.0
- Lexical Diversity: 1.47059
- Patent Class: 424.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['11921676', '14384910', '11256685', '11685674', '11330033']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7634040343109645
- 35 USC 102 Novelty (BERT): 0.55515300053681
- Combined Prediction Score: 0.7425789309335491
- Mean Citation Score: 322.81307400000014
- Max Citation Score: 416.39224
- Similarity Product: 341.0393689032888

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test